...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: RVXOT
3
May 05, 2020 06:31PM

KOO - Regardless of what we think, I believe that is how it is. If I remember correctly, the RPS are owned by ZCC which makes them the property of all ZCC shareholders, not just the shareholders at time of company split. It is fair if there is enough built into the share price of any newly issued shares to cover the value of the RPS but how do we judge that?

1
May 06, 2020 09:21AM
1
May 06, 2020 11:02AM
1
May 06, 2020 11:13AM
1
May 06, 2020 11:59AM
1
May 06, 2020 01:36PM
1
May 06, 2020 02:32PM
Share
New Message
Please login to post a reply